Research Publications
The latest from Maverex.
Latest Posts
Find our peer-reviewed research publications across oncology, cardiovascular, infectious disease and much more.
Identification of Cost-Effectiveness Evidence in UK NICE Single Technology Assessment Company Submissions: Databases, Sources and Currency of Searching (Copy)
ISPOR US 2024: Poster Session: 1. May 6th 2024. Poster Session Time: 10:30-13:30. Discussion Period: 12:30-13:30.
Patient engagement process in rare disease: how does it differ between countries?
Skeldon G, Adkins E, Ayre S, Langham S, Nicholson L. PRO95 Patient engagement process in rare disease: how does it differ between countries? Value Health 2020;23(Suppl 2):S706
A review of exceptional circumstances marketing authorisations granted by the European Medicines Agency
Marjenberg Z, Teague R, Skeldon G. PMU50 A review of exceptional circumstances marketing authorisations granted by the European Medicines Agency. Value Health 2020;23(Suppl 2):S611
The patient perspective in health technology assessment reimbursement decisions for orphan drugs across different countries
Nicholson L, Langham S, Adkins E. The patient perspective in health technology assessment reimbursement decisions for orphan drugs across different countries. Value Health 2019:22(Suppl 3):S860
Choosing the right software for HTA economic models: a comparison of four programmes recommended by the National Institute for Health and Care Excellence
Wright A, Embleton N, Langham S. Choosing the right software for HTA economic models: a comparison of four programmes recommended by the National Institute for Health and Care Excellence. Value Health 2018;21(Suppl 3):S380
Health technology assessment of companion diagnostics alongside therapeutic agents in oncology: experience of the NICE technology appraisal programme
Langham S, Lewis J. Health technology assessment of companion diagnostics alongside therapeutic agents in oncology: experience of the NICE technology appraisal programme. Value Health 2018;21(Suppl 3):S272
Conducting and reporting indirect treatment comparisons: a critical appraisal of oncology technology appraisals
Langham J, Langham S. Conducting and reporting indirect treatment comparisons: a critical appraisal of oncology technology appraisals. Value Health 2018;21(Suppl 3):S68
